Henning Beck-Nielsen

发表

The pharmacogenetics of metformin and its impact on plasma metformin steady-state levels and glycosylated hemoglobin A1c

Per Damkier, Henrik Green, Flemming Nielsen, 2011, Pharmacogenetics and genomics.

Elevated Atherosclerosis-Related Gene Expression, Monocyte Activation and Microparticle-Release Are Related to Increased Lipoprotein-Associated Oxidative Stress in Familial Hypercholesterolemia

Aase Handberg, H. Beck-Nielsen, A. Handberg, 2015, PLoS ONE.

Outcomes in type 1 diabetic pregnancies: a nationwide, population-based study.

H. Beck-Nielsen, P. Damm, Henning Beck-Nielsen, 2005, Diabetes care.

Plasma FGF21 displays a circadian rhythm during a 72‐h fast in healthy female volunteers

Birgitte Andersen, K. Højlund, H. Beck-Nielsen, 2011, Clinical endocrinology.

Detecting hypoglycemia by using the brain as a biosensor

Line Sofie Remvig, Henning Beck-Nielsen, Claus B. Juhl, 2011 .

Detection of hypoglycemia associated EEG changes during sleep in type 1 diabetes mellitus.

Line Sofie Remvig, H. Beck-Nielsen, B. Thorsteinsson, 2012, Diabetes research and clinical practice.

Impact of two common polymorphisms in the PPARgamma gene on glucose tolerance and plasma insulin profiles in monozygotic and dizygotic twins: thrifty genotype, thrifty phenotype, or both?

Allan Vaag, Torben Hansen, Pernille Poulsen, 2003, Diabetes.

The effects of capillary dysfunction on oxygen and glucose extraction in diabetic neuropathy

Leif Østergaard, Sune N. Jespersen, Nanna B. Finnerup, 2014, Diabetologia.

Proteome Analysis Reveals Phosphorylation of ATP Synthase β-Subunit in Human Skeletal Muscle and Proteins with Potential Roles in Type 2 Diabetes*

Aase Handberg, Peter Roepstorff, Peter Mose Larsen, 2003, The Journal of Biological Chemistry.

Automated detection of hypoglycemia-induced EEG changes recorded by subcutaneous electrodes in subjects with type 1 diabetes--the brain as a biosensor.

Jens Juul Holst, J. Holst, K. Højlund, 2010, Diabetes research and clinical practice.

Heart failure events with rosiglitazone in type 2 diabetes: data from the RECORD clinical trial

Markolf Hanefeld, John J.V. McMurray, M. Hanefeld, 2010, European heart journal.

Efficacy and safety of the PPARγ partial agonist balaglitazone compared with pioglitazone and placebo: a phase III, randomized, parallel‐group study in patients with type 2 diabetes on stable insulin therapy

Claus Christiansen, Hans Perrild, Inger Byrjalsen, 2011, Diabetes/metabolism research and reviews.

Total and regional fat distribution is strongly influenced by genetic factors in young and elderly twins.

Kaare Christensen, Arne Astrup, Pernille Poulsen, 2005, Obesity research.

Characterization of Human Myotubes From Type 2 Diabetic and Nondiabetic Subjects Using Complementary Quantitative Mass Spectrometric Methods*

Ole N Jensen, Michael Gaster, O. Jensen, 2011, Molecular & Cellular Proteomics.